Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease

Publisher： Karger

E-ISSN： 2296-9357|3|1|15-23

ISSN： 2296-9381

Source： Kidney Diseases, Vol.3, Iss.1, 2016-11, pp. : 15-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Klotho: Relation to Fibroblast Growth Factor-23 and Other Regulators of Phosphate Metabolism in Children with Chronic Kidney Disease

By  

Nephron, Vol. 129, Iss. 4, 2015-03 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Diagnosis of Cardiovascular Disease in Patients with Chronic Kidney Disease

By  

Blood Purification, Vol. 33, Iss. 1-3, 2012-01 ,pp. : 112-118

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-10 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

Cardiovascular Imaging in Patients with Chronic Kidney Disease

By  

Blood Purification, Vol. 31, Iss. 1-3, 2011-01 ,pp. : 130-137

Karger

Access to resources Recommend Favorite

Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 146-148

Karger

Access to resources Recommend Favorite